The present investigation showed that ANRIL in the plasma of patients with stable angina increased more remarkably than the traditional index: cardiac troponin I, suggesting ANRIL can be used as a diagnostic biomarker for stable angina. The gene discussed is CDKN2B-AS1; the disease is angina pectoris.